A detailed history of Cromwell Holdings LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cromwell Holdings LLC holds 3,185 shares of GILD stock, worth $307,575. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,185
Previous 3,185 -0.0%
Holding current value
$307,575
Previous $218,000 22.02%
% of portfolio
0.18%
Previous 0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $201,132 - $232,122
3,185 New
3,185 $218,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $121B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cromwell Holdings LLC Portfolio

Follow Cromwell Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cromwell Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cromwell Holdings LLC with notifications on news.